SOURCE: S3 Investment Company

December 19, 2006 09:02 ET

S3 Investment Company CEO Schedules China Trip to Prepare for New Product Roll-Outs and Additional Investment Banking Deals for Subsidiaries

TEMECULA, CA -- (MARKET WIRE) -- December 19, 2006 -- S3 Investment Company, Inc. (PINKSHEETS: SEIH), a holding company with two subsidiaries doing business in the China market, today announced CEO Jim Bickel has scheduled a January trip to China to prepare for new product roll-outs for its SINO UJE subsidiary and increased investment banking services for its Redwood Capital subsidiary.

Prominent on this trip will be meetings in Hong Kong with Chief Capital and Chief Securities, which have worked with Redwood Capital as it assists private Chinese companies access the U.S. capital markets through reverse merger transactions.

"Our goal is to not only increase the number of quality reverse merger candidates we are working with, but to also expand the role that Redwood Capital takes with each reverse merger transaction," stated Mr. Bickel. "We have an excellent working relationship with Chief and its General Manager, Dr. Hu Cheng, and look forward to expanding our association so that Redwood Capital has steady deal flow. Each transaction can have such a significant impact on S3's bottom line that we are consistently focused on establishing relationships that will result in a greater number of completed deals for Redwood Capital."

In addition to the Hong Kong meetings with Chief, Mr. Bickel is planning visits with SINO UJE management, which is preparing for the roll-out of the product line of new supplier Abaxis, Inc., a publicly traded company that develops, manufactures and markets portable blood analysis systems for use in patient-care setting to provide clinicians with rapid blood constituent measurements. Once SFDA approval is achieved in China, SINO UJE expects to have in place a comprehensive sales and marketing effort on behalf of the Abaxis products.

"Abaxis is an extremely important product line that we believe has almost limitless potential in China," commented Mr. Bickel. "Once this line has regulatory approval here, we expect it to become a tremendously important supplier that will directly impact the revenues for our SINO UJE subsidiary. Planning for roll-out is an important aspect of successfully integrating Abaxis products into SINO UJE's distribution network."

S3 management is scheduled to attend meetings in Shanghai, Beijing, and other business locations of its subsidiaries. They are also scheduled to attend an investors group meeting in Beijing during this trip.

The company will report on the important events of the trip as they occur as well as providing a detailed report after the visit is complete.

To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.s3investments.com/ealert.php.

About S3 Investment Company

S3 Investment Company, Inc. (http://www.s3investments.com) is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (http://www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China. SINO UJE has been granted exclusive distribution rights in China to medical and industrial products manufactured by leading companies in Europe, North America and Japan. These products are marketed to end-users, including major Chinese hospitals and private companies in a variety of fields, as well as original equipment manufacturers (OEMs), such as Phillips, Siemens and GE, that package the products with their technologies.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    (951) 587-8072
    Email Contact